Protagenic Therapeutics, Inc. (PTIX)
OTCMKTS · Delayed Price · Currency is USD
0.5000
0.00 (0.00%)
At close: Jun 5, 2026
Protagenic Therapeutics Market Cap
Protagenic Therapeutics has a market cap or net worth of $952.89 thousand as of June 8, 2026.
Market Cap
952.89K
Enterprise Value
2.74M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.50
Market Cap Chart
Since May 19, 2025, Protagenic Therapeutics's market cap has decreased from 9.64M to 952.89K, a decrease of -90.11%. That is a compound annual growth rate of -89.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 905.10K | -64.02% |
| Dec 31, 2025 | 2.52M | -73.91% |
| May 19, 2025 | 9.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Burzynski Research Institute | 1.34M |
| Lyra Therapeutics | 1.24M |
| Avenue Therapeutics | 1.16M |
| Abpro Holdings | 1.15M |
| Evofem Biosciences | 1.09M |
| Agentix | 841.41K |
| Halberd | 747.30K |
| Emmaus Life Sciences | 715.92K |